semaglutide lean mass loss on GLP-1 receptor agonists: a downside of the “miracle drugs” Semaglutide and muscle loss: Hidden
Description
Waiting is not a safe option
Part D obesity coverage begins January 2027 Need financial help
Clinical trials report gallstone formation rates of 1015% over one year in rapid weight-loss cohorts
Semaglutide (Ozempic and Wegovy) come as pre-filled subcutaneous weekly injections that are injected under the skin of your stomach (abdomen), thigh, or upper arm
Many private insurers will approve these drugs when prescribed for diabetes management but exclude them when used primarily for weight loss
Nielsen LL, Young AA, Parkes DG
